Collectively, the data suggest that extracellular ASC released by tumor cells induces IL-1β secretion in TAMs that in turn activates TSLP by CAFs and that ASC is expressed in a high percentage of primary tumors where its expression correlates with reduced survival in PDAC patients. Here, IL1B is linked to neoplasm.